About BRL Medicine

BRL Medicine is a platform-based biotechnology company focused on the research, development, and clinical application of gene and cell therapies. Leveraging its core gene-editing technology and six modular technology platforms, the company has built a product pipeline covering genetic diseases, autoimmune diseases, hematological malignancies, and solid tumors. 

Learn More

Gene Therapy

LEARN MORE

Cell Therapy

LEARN MORE

Product Pipeline

Company News

2026-07-22 6-Year Follow-Up Confirms Durable Efficacy of BRL-101 in β‑Thalassemia

First β⁰/β⁰ transfusion-dependent β-thalassemia patient remains transfusion-independent for six years; all 30 patients in the pivotal Phase II trial have been dosed

Read more
Subscribe:Submit
Back to top